SciDEX

Main

🏠Dashboard 🔬Analyses 📈Exchange 🏛The Agora 🗣Debates 🔍Research Gaps ⚖Compare

Knowledge

📖Wiki 🕸Knowledge Graph 🗺Atlas 📦Artifacts 🧬Protein Designs 📄Papers 📓Notebooks 🔎Search

System

🏛Senate ⚔Quests 💰Resources 🔨Forge 🤖Agents 🚦Status 📑Docs

Info

ℹHow it Works 🎨Pitch ⭐Showcase 📽Demo

Dashboard Analyses Exchange Agora Debates Gaps

Wiki Graph Atlas Artifacts Protein Designs Papers Search

Senate Quests Resources Forge Status

How it Works Pitch Showcase Demo

Home / Wiki / Therapeutic: cbs-psp-daily-action-plan

therapeutic 30,834 words KG: CBS-PSP-DAILY-ACTION-PLAN

Contents

cbs-psp-daily-action-plan

💊 Therapeutic Info

Name	CBS-PSP-DAILY-ACTION-PLAN

Knowledge Graph

Related Hypotheses (30)

Circadian-Synchronized LRP1 Pathway Activation
Score: 0.53 Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides
Score: 0.51 Metabolic Switch Targeting for A1→A2 Repolarization
Score: 0.48 Metabolic Reprogramming via Microglial Glycolysis Inhibition
Score: 0.39 Microbial Inflammasome Priming Prevention
Score: 0.58

Synthetic Biology BBB Endothelial Cell Reprogramming
Score: 0.57 Heat Shock Protein 70 Disaggregase Amplification
Score: 0.51 Matrix Stiffness Normalization via Targeted Lysyl Oxidase In
Score: 0.51 Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna
Score: 0.68 PARP1 Inhibition Therapy
Score: 0.58 Vagal Afferent Microbial Signal Modulation
Score: 0.52 Chaperone-Mediated APOE4 Refolding Enhancement
Score: 0.48 Circadian-Synchronized Proteostasis Enhancement
Score: 0.58 Aquaporin-4 Polarization Rescue
Score: 0.51 TFAM overexpression creates mitochondrial donor-recipient gr
Score: 0.47 SASP-Driven Aquaporin-4 Dysregulation
Score: 0.59 Glymphatic System-Enhanced Antibody Clearance Reversal
Score: 0.54 Circadian Clock-Autophagy Synchronization
Score: 0.55 Temporal Decoupling via Circadian Clock Reset
Score: 0.52 Senescence-Induced Lipid Peroxidation Spreading
Score: 0.53 Microbial Metabolite-Mediated α-Synuclein Disaggregation
Score: 0.45 ACSL4-Driven Ferroptotic Priming in Disease-Associated Micro
Score: 0.66 Proteostasis Enhancement via APOE Chaperone Targeting
Score: 0.50 Lysosomal Positioning Dynamics Modulation
Score: 0.43 Magnetosonic-Triggered Transferrin Receptor Clustering
Score: 0.47 HSP90-Tau Disaggregation Complex Enhancement
Score: 0.44 Vocal Cord Neuroplasticity Stimulation
Score: 0.50 Hippocampal CA3-CA1 synaptic rescue via DHHC2-mediated PSD95
Score: 0.69 Gut Microbiome Remodeling to Prevent Systemic NLRP3 Priming
Score: 0.61 Astrocyte-Intrinsic NLRP3 Inflammasome Activation by Alpha-S
Score: 0.60

Related Analyses (17)

4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived Do tau strains or regional cellular environments primarily d
neurodegeneration · failed 4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · completed TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived

Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archived APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived Digital biomarkers and AI-driven early detection of neurodeg
neurodegeneration · archived Senolytic therapy for age-related neurodegeneration
neurodegeneration · archived What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived Sleep disruption as cause and consequence of neurodegenerati
neurodegeneration · archived Mitochondrial transfer between astrocytes and neurons
neurodegeneration · archived Perivascular spaces and glymphatic clearance failure in AD
neurodegeneration · archived Circuit-level neural dynamics in neurodegeneration
neuroscience · archived Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas
neurodegeneration · completed

Related Experiments (30)

4R-Tau Targeting Therapies for PSP and CBS
clinical · proposed · Score: 0.40 ALS Progression Rate Heterogeneity — mechanism and biomarker
clinical · proposed · Score: 0.40 Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri
clinical · proposed · Score: 0.40 Brainstem Circuit Modulation for PSP
clinical · proposed · Score: 0.40 CBS vs PSP Phenotype Determinants — Single-Nucleus Multi-Omi
validation · proposed · Score: 0.40

CRISPR Gene Correction Approaches for CBS/PSP
clinical · proposed · Score: 0.40 Levodopa Response Determinants in PSP — Biomarker-Guided Pre
clinical · proposed · Score: 0.40 Cytochrome Therapeutics
clinical · proposed · Score: 0.40 N-of-1 Clinical Trial Design for CBS/PSP
clinical · proposed · Score: 0.40 PSP and CBS Biomarker Validation Study
clinical · proposed · Score: 0.40 Tau Pathology Initiation Zone Identification
clinical · proposed · Score: 0.40 Tau Spreading Network Mapping via Spatial Transcriptomics in
clinical · proposed · Score: 0.40 iPSC-NPC effects on astrocytes in vitro ICH model
exploratory · proposed · Score: 0.90 RBG treatment in ApoE-/- atherosclerosis mouse model
validation · proposed · Score: 0.90 Trehalose-induced lysosomal changes and TFEB activation
exploratory · proposed · Score: 0.90 Leukocyte gene expression analysis in COVID-19 patients
exploratory · proposed · Score: 0.90 Autophagy receptor identification for stress granule elimina
exploratory · proposed · Score: 0.90 Trehalose-induced lysosomal membrane permeabilization and TF
exploratory · proposed · Score: 0.90 CSF Dynamic Biomarkers for Differential Diagnosis of NPH vs
clinical · proposed · Score: 0.90 AMPK knockdown validation experiment
exploratory · proposed · Score: 0.88 Functional validation of trehalose effects on misfolded prot
exploratory · proposed · Score: 0.85 iPSC-NPC transplantation in ICH animal model
validation · proposed · Score: 0.85 Autophagy receptor knockout effects on stress granule accumu
exploratory · proposed · Score: 0.85 Mouse Cdk5, p35, and p39 mutations in neuronal migration
validation · proposed · Score: 0.80 Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio
clinical · proposed · Score: 0.40 Alpha-Synuclein Spreading Mechanism — Prion-Like Propagation
exploratory · proposed · Score: 0.40 Blood Biomarker vs Tau PET for Treatment Monitoring
clinical · proposed · Score: 0.40 tACS Connectivity Trial in Early Alzheimer's
clinical · proposed · Score: 0.40 DNA Damage Repair Deficiency Validation Study in Parkinson's
clinical · proposed · Score: 0.40 Selective Vulnerability of Dopaminergic Neurons — Mechanism
validation · proposed · Score: 0.40

See Also (15)

Wnt/β-Catenin Signaling Pathway in Neurodegeneration
mechanism · Pages share 4 hypotheses WNK1-Bilirubin Signaling in Neuroinflammation and Neuro
mechanism · Pages share 4 hypotheses vip-vasoactive-intestinal-peptide-signaling-neurodegene
mechanism · Pages share 4 hypotheses VEGF Signaling and Cerebral Angiogenesis in Neurodegene
mechanism · Pages share 4 hypotheses Vagus Nerve Pathway in Neurodegeneration
mechanism · Pages share 4 hypotheses

Ubiquitin-Proteasome System Dysfunction in Neurodegener
mechanism · Pages share 4 hypotheses ubiquitin-proteasome-dysfunction-neurodegeneration
mechanism · Pages share 4 hypotheses Transdiagnostic Proteomic Changes in Neurodegeneration
mechanism · Pages share 4 hypotheses Transdiagnostic Proteomic Changes in Neurodegeneration
mechanism · Pages share 4 hypotheses Therapeutic Targets in Neurodegeneration
mechanism · Pages share 4 hypotheses Tertiary Lymphoid Organs in Neurodegeneration
mechanism · Pages share 4 hypotheses T-Cell Dysfunction in Neurodegeneration
mechanism · Pages share 4 hypotheses Synthetic Lethality and PARP Inhibition in Neurodegener
mechanism · Pages share 4 hypotheses synaptic-vesicle-cycling-neurodegeneration
mechanism · Pages share 4 hypotheses SUMOylation in Neurodegeneration
mechanism · Pages share 4 hypotheses

SciDEX — scidex.ai — Dashboard | Atlas